{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:17:36Z","timestamp":1785842256487,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","award":["20110071120099"],"award-info":[{"award-number":["20110071120099"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.ygyno.2015.11.021","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T04:30:20Z","timestamp":1448339420000},"page":"58-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Adjuvant concurrent chemoradiation followed by chemotherapy for high-risk endometrial cancer"],"prefix":"10.1016","volume":"140","author":[{"given":"Yulan","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boer","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daren","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2015.11.021_bb0005","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.11.021_bb0010","first-page":"445","article-title":"Epidemiology of uterine corpus cancer in some cancer registering areas of China from 2003\u20132007","volume":"47","author":"Wei","year":"2012","journal-title":"Chinese Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1016\/j.ygyno.2015.11.021_bb0015","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ajog.2007.08.075","article-title":"Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths","volume":"198","author":"Ueda","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0020","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0025","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Postoperative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2015.11.021_bb0030","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ijrobp.2011.04.013","article-title":"Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma","volume":"81","author":"Creutzberg","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"ASTEC\/EN.5 Study Group","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2015.11.021_bb0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study","volume":"24","author":"Randall","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0045","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ygyno.2004.02.008","article-title":"Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III\u2013IV endometrial cancer patients","volume":"93","author":"Bruzzone","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0050","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1200\/JCO.2001.19.20.4048","article-title":"Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study","volume":"19","author":"Hoskins","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0055","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ygyno.2009.11.019","article-title":"Adjuvant treatment with concomitant radiotherapy and chemotherapy in high-risk endometrial cancer: a clinical experience","volume":"116","author":"De Marzi","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.11.021_bb0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2007.06.014","article-title":"The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer","volume":"107","author":"Secord","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2006.02.007","article-title":"Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin\/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer","volume":"103","author":"Greven","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0070","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2008.10.006","article-title":"Concurrent carboplatin\/paclitaxel and intravaginal radiation in surgical stage I\u2013II serous endometrial cancer","volume":"112","author":"Alektiar","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejogrb.2013.06.009","article-title":"The benefit of adjuvant chemotherapy combined with postoperative radiotherapy for endometrial cancer: a meta-analysis","volume":"170","author":"Park","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0080","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann. Stat."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparameteric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J. Am. Stat. Assoc."},{"issue":"3","key":"10.1016\/j.ygyno.2015.11.021_bb0090","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ygyno.2009.06.005","article-title":"A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer","volume":"114","author":"Secord","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0095","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2010.06.002","article-title":"Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer\u2013results from two randomised studies","volume":"46","author":"Hogberg","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.11.021_bb0100","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00280-013-2276-9","article-title":"Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology)","volume":"72","author":"Mustea","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ygyno.2009.03.027","article-title":"Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer","volume":"114","author":"Lupe","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ygyno.2010.12.338","article-title":"A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a \u201csandwich\u201d method for stage III, IV, and recurrent endometrial cancer","volume":"121","author":"Geller","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0115","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1447-0756.2006.00405.x","article-title":"Paclitaxel\/carboplatin versus cyclophosphamide\/adriamycin\/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma","volume":"32","author":"Hidaka","year":"2006","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ygyno.2006.03.019","article-title":"Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: a retrospective study","volume":"03","author":"Sovak","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0125","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.ajog.2004.12.032","article-title":"Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer","volume":"92","author":"Akram","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ygyno.2008.01.028","article-title":"Carboplatin and paclitaxel in advanced or metastatic endometrial cancer","volume":"109","author":"Pectasides","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0135","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1525-1438.2007.01094.x","article-title":"Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel-long-term follow-up","volume":"18","author":"Sorbe","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2015.11.021_bb0140","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ygyno.2012.03.034","article-title":"Late-breaking Abstract 1: Randomized phase III noninferiority trial of first line chemotherapy for metastatic or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study","volume":"125","author":"Miller","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ygyno.2004.06.041","article-title":"Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin\/cisplatin chemotherapy for advanced stage endometrial cancer: a Gynecologic Oncology Group trial","volume":"95","author":"Soper","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.11.021_bb0150","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ygyno.2008.11.026","article-title":"Sequential chemotherapy and irradiation in advanced stage endometrial cancer: a Gynecologic Oncology Group phase I trial of doxorubicin-cisplatin followed by whole abdomen irradiation","volume":"112","author":"Fowler","year":"2009","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815301931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815301931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T09:05:48Z","timestamp":1655370348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815301931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0090825815301931"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.11.021","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant concurrent chemoradiation followed by chemotherapy for high-risk endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}